BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34880312)

  • 21. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P; Sinniger J; El Oussini H; Scekic-Zahirovic J; Dieterlé S; Dengler R; Meyer T; Zierz S; Kassubek J; Fischer W; Dreyhaupt J; Grehl T; Hermann A; Grosskreutz J; Witting A; Van Den Bosch L; Spreux-Varoquaux O; ; Ludolph AC; Dupuis L
    Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
    Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C
    PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Timing and Extent of Motor Neuron Vulnerability in ALS Correlates with Accumulation of Misfolded SOD1 Protein in the Cortex and in the Spinal Cord.
    Genc B; Gozutok O; Kocak N; Ozdinler PH
    Cells; 2020 Feb; 9(2):. PubMed ID: 32098365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
    Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.
    Barbeito AG; Martinez-Palma L; Vargas MR; Pehar M; Mañay N; Beckman JS; Barbeito L; Cassina P
    Neurobiol Dis; 2010 Mar; 37(3):574-80. PubMed ID: 19914377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1
    Borkowski LF; Craig TA; Stricklin OE; Johnson KA; Nichols NL
    Respir Physiol Neurobiol; 2020 Aug; 279():103471. PubMed ID: 32504811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
    Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
    J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient, 5-HT2B receptor-mediated facilitation in neuropathic pain: Up-regulation of PKCγ and engagement of the NMDA receptor in dorsal horn neurons.
    Aira Z; Buesa I; García Del Caño G; Bilbao J; Doñate F; Zimmermann M; Azkue JJ
    Pain; 2013 Sep; 154(9):1865-1877. PubMed ID: 23769718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin 5-HT2B Receptor-Stimulated DNA Synthesis and Proliferation Are Mediated by Autocrine Secretion of Transforming Growth Factor-α in Primary Cultures of Adult Rat Hepatocytes.
    Naito K; Moteki H; Kimura M; Natsume H; Ogihara M
    Biol Pharm Bull; 2016; 39(4):570-7. PubMed ID: 26804134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis.
    Shavit-Stein E; Abu Rahal I; Bushi D; Gera O; Sharon R; Gofrit SG; Pollak L; Mindel K; Maggio N; Kloog Y; Chapman J; Dori A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.
    Ozdinler PH; Benn S; Yamamoto TH; Güzel M; Brown RH; Macklis JD
    J Neurosci; 2011 Mar; 31(11):4166-77. PubMed ID: 21411657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rodent Models of Amyotrophic Lateral Sclerosis.
    Philips T; Rothstein JD
    Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Little Helpers or Mean Rogue-Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis.
    Cihankaya H; Theiss C; Matschke V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.
    Seredenina T; Nayernia Z; Sorce S; Maghzal GJ; Filippova A; Ling SC; Basset O; Plastre O; Daali Y; Rushing EJ; Giordana MT; Cleveland DW; Aguzzi A; Stocker R; Krause KH; Jaquet V
    Free Radic Biol Med; 2016 Aug; 97():95-108. PubMed ID: 27212019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms involved in the protective effect of pituitary adenylate cyclase-activating polypeptide in an in vitro model of amyotrophic lateral sclerosis.
    Maugeri G; D'Amico AG; Rasà DM; Federico C; Saccone S; Morello G; La Cognata V; Cavallaro S; D'Agata V
    J Cell Physiol; 2019 Apr; 234(4):5203-5214. PubMed ID: 30238989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
    Ng SK; Higashimori H; Tolman M; Yang Y
    Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity.
    Dentel C; Palamiuc L; Henriques A; Lannes B; Spreux-Varoquaux O; Gutknecht L; René F; Echaniz-Laguna A; Gonzalez de Aguilar JL; Lesch KP; Meininger V; Loeffler JP; Dupuis L
    Brain; 2013 Feb; 136(Pt 2):483-93. PubMed ID: 23114367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.